Rea provides the latest diagnostic technology to detect a risk
of a preterm birth

Preterm birth is one the main

challenges in healthcare

Prematurity is the main cause of death of infants, while children born preterm are likely to have long-term neurological and developmental disorders.

Half of the women that deliver a preterm baby have no risk factors and present no symptoms. Meaning that it’s impossible for them and their doctors to foresee a preterm birth.

1 out of 10 women deliver preterm

Doctors don’t know which of their patients will deliver preterm.

Therefore, 85% of the hospitalised women considered under PTB risk do not deliver within the next 7 days.

To diagnose a preterm birth, doctors have to wait until a patient show symptoms, but 50% of the cases are completely unexpected.

Preterm birth risk assessment is a major challenge in obstetrics care, being the first cause of perinatal mortality and morbidity.

Half of all premature kids are born without preventive-medical intervention.

  • In Switzerland, 33% of infant deaths occurred among infants born preterm (
  • In the US, 66% of infant deaths occurred among infants born preterm (

Our offer


To perform a biomarker test for preterm birth, doctors require an invasive procedure and they have to perform cervical swab in the hospital.

with REA

We offer the same biochemical test but in a friendly format. Thanks to our Smart Pad, women can perform themselves a preterm birth test at home.

We want to offer every woman a safe pregnancy.

Our technology provides an early alert to doctors so they can take the required medical action to save lives

Dr. David Baud is the Head of Obstetrics of Lausanne University Hospital.

He is leading the clinical validation
of our Smart Pad.

Knowing when the patient will deliver makes a huge difference for the health of the baby.